Reuters logo
BRIEF-Cadila Healthcare says Zydus gets regulatory nod for lipaglyn (saroglitazar magnesium) ‍​in Mexico
November 10, 2017 / 5:47 AM / 11 days ago

BRIEF-Cadila Healthcare says Zydus gets regulatory nod for lipaglyn (saroglitazar magnesium) ‍​in Mexico

Nov 10 (Reuters) - Cadila Healthcare Ltd

* Zydus gets marketing approval from Mexico regulatory authority to commercialize lipaglyn (saroglitazar magnesium)‍​ Source text - bit.ly/2hZI4W9 Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below